Bareminerals Blemish Remedy Acne Treatment Gelee Cleanser Emulsion
NDC Package 98132-770-01
Package Information
Bareminerals Blemish Remedy Acne Treatment Gelee Cleanser (salicylic acid) emulsions is cover the entire affected area with a thin layer of product and rinse thoroughly one to three times dailybecause excessive drying out of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctorif bothersome dryness or peeling occurs, reduce application to once a day or every other day. This formulation utilizes a emulsion delivery system. Marketed by Orveon Global Us Llc, this product is identified by NDC 98132-770 and is authorized under FDA application M006.
Identification & Billing
- RxCUI: 1038982 - salicylic acid 1 % Medicated Liquid Soap
- RxCUI: 1038982 - salicylic acid 10 MG/ML Medicated Liquid Soap
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 98132 - Orveon Global Us Llc
- 98132-770 - Bareminerals Blemish Remedy Acne Treatment Gelee Cleanser
- 98132-770-01 - 1 TUBE in 1 CARTON / 120 g in 1 TUBE
- 98132-770 - Bareminerals Blemish Remedy Acne Treatment Gelee Cleanser
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 98132-770-01 identifies a specific commercial package of 1 tube in 1 carton / 120 g in 1 tube of Bareminerals Blemish Remedy Acne Treatment Gelee Cleanser, a human over the counter drug labeled by Orveon Global Us Llc. This emulsion is formulated for topical use and contains salicylic acid as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Orveon Global Us Llc on January 30, 2016. The current certification is valid through December 31, 2027.
How is this Orveon Global Us Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 98132077001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.